Amgen Inc.(AMGN)Stock Performance & ReturnsNASDAQ
Returns, drawdowns and benchmark comparison
Peer Comparison
Relative scale, growth, and profitability vs sector peers
| Ticker | Market Cap | P/E Ratio | Revenue Growth | Net Margin | EPS | ROE | Debt/Equity | Dividend Yield | 52W High | 52W Low |
|---|---|---|---|---|---|---|---|---|---|---|
AMGN | 223.32 B | 26.55x | 9.50% | 22.95% | $15.56 | 91.47% | 4.90x | 2.41% | $447.03 | $288.00 |
LLY | 1.06 T | 40.23x | 47.70% | 33.53% | $29.55 | 102.29% | 1.62x | 0.56% | $1292.65 | $778.94 |
JNJ | 622.84 B | 30.66x | 6.60% | 21.48% | $8.43 | 25.74% | 0.58x | 2.03% | $281.07 | $178.91 |
ABBV | 479.52 B | 77.31x | 10.20% | 9.80% | $3.51 | - | - | 2.63% | $269.39 | $189.40 |
AZN | 248.33 B | 23.97x | 6.40% | 17.02% | $6.68 | 21.97% | 0.64x | 2.05% | $210.52 | $153.41 |
NVO | 127.82 B | 9.71x | 2.10% | 35.35% | $3.94 | 59.82% | 0.63x | 31.28% | $61.11 | $34.15 |
Peer Valuation & Performance Analysis
Peer group analysis for Amgen Inc. (AMGN) compared to its primary competitors (including LLY, JNJ, ABBV) reveals distinct metrics. AMGN trades at a valuation discount relative to its competitors, with a P/E ratio of 26.5x versus the peer average of 37.0x (representing a 28% discount). This discount might represent an undervalued entry opportunity or reflect specific risk factors the market is discounting. In terms of growth, AMGN's revenue growth of 9.5% lags behind the peer average of 12.7%, indicating potential market share losses or slower industry adoption. Additionally, it boasts superior profitability with a net margin of 22.9% compared to the peer average of 20.9%, demonstrating strong cost controls and pricing power.
Peer Performance Rankings
Ranking comparison across key performance metrics
P/E Ratio (Lower is Better)
Revenue Growth
Net Profit Margin
Financial Rankings Summary
• AMGN ranks #2 in P/E ratio, #3 in revenue growth, and #2 in profit margins
• Average ranking: #2 - 🎯 Top-tier fundamentals relative to peer group
• Rankings based on actual financial data from company reports
Historical Trading Data
Price and volume data with customizable timeframes
Showing 15 of 15 trading sessions from the last 15 days
| Date | Open | High | Low | Close | Volume | Daily Change |
|---|---|---|---|---|---|---|
| 2026-10-07 | $403.06 | $415.79 | $401.85 | $413.08 | 2,236,500 | +2.60% |
| 2026-10-06 | $403.30 | $405.00 | $396.01 | $402.60 | 2,036,500 | -0.09% |
| 2026-10-05 | $399.03 | $403.69 | $397.03 | $402.98 | 3,103,900 | -0.01% |
| 2026-10-02 | $410.16 | $410.16 | $401.96 | $403.04 | 3,510,200 | -1.04% |
| 2026-10-01 | $421.72 | $422.80 | $407.13 | $407.27 | 2,500,500 | -3.38% |
| 2026-09-30 | $424.01 | $426.59 | $420.63 | $421.51 | 3,129,500 | -0.50% |
| 2026-09-29 | $414.37 | $424.57 | $414.11 | $423.64 | 3,737,800 | +1.32% |
| 2026-09-28 | $411.52 | $419.02 | $410.96 | $418.13 | 2,917,900 | +0.85% |
| 2026-09-25 | $408.25 | $415.20 | $404.19 | $414.61 | 2,213,100 | +2.11% |
| 2026-09-24 | $406.09 | $409.99 | $403.88 | $406.04 | 2,525,000 | -0.01% |
| 2026-09-23 | $410.09 | $415.76 | $404.34 | $406.09 | 2,822,500 | -1.01% |
| 2026-09-22 | $405.25 | $413.00 | $398.52 | $410.24 | 3,720,300 | +4.34% |
| 2026-09-21 | $385.71 | $394.50 | $381.90 | $393.16 | 2,889,000 | +1.95% |
| 2026-09-18 | $378.51 | $386.50 | $378.51 | $385.65 | 8,523,800 | +1.55% |
| 2026-09-17 | $379.15 | $382.49 | $376.08 | $379.78 | 3,234,700 | +0.91% |
Explore More Analysis for AMGN
Additional research, tools, and technical breakdowns
Stock Analyzer Report
Deep-dive automated research and stock rating report.
DCF Fair Value Calculator
Discounted cash flow model and intrinsic value projection.
AI Price Predictions
Multi-scenario price predictions and consensus targets.
Insider Activity Tracker
Track buying/selling behavior of corporate insiders.
Earnings Calendar
Track upcoming and historical corporate earnings reports.
Market Insights & Research
Read the latest analysis articles and expert research.